Company Analysis
Sign in

ANI Pharmaceuticals, Inc. (ANIP)

Nasdaq: ANIP · Pharmaceutical Preparations · Baudette, MN · filing with the SEC since 1999
Full chart Alerts Compare
Grade6.3
◀ Past 6.3● Present 6.6▶ Future 5.8
OverviewBusinessFinancialsGradeForecastSentimentOwnershipPeopleFilingsPatents Chart

Patents

US patents through Dec 31, 2025 · PatentsView, from the USPTO’s Open Data Portal · read Oct 27, 2026

28 patents granted to the 6 names below, as the owner printed on each patent when it was granted. A later sale, a lapse or an expiry is not read, so this is what was granted to ANI Pharmaceuticals, Inc.’s names, not what it holds today.

Patents granted
28
27 utility, 1 design, 1976 to Dec 31, 2025
Granted in 2025
5
Against 5 in 2024 and 1 in 2023
Applications published
24
1 of them in 2025
Names they are printed under
6
a former name, its own name, a subsidiary
By yearGrantedApplications published
'01'02'09'10'11'12'13'17'19'22'23'24'25
Each pair is one calendar year. Applications are published about eighteen months after filing, so the newest years read low.
What they are aboutgrants since 2021
Pharmaceuticals7
Medical technology6
The main technology area of each patent, in the World Intellectual Property Organization’s 35 fields.
Under which name6 counted
BioSante Pharmaceuticals, Inc. a former name
US, as the owner printed on each patent
12 granted
10 published
ANI Pharmaceuticals, Inc. its own name
US, as the owner printed on each patent
8 granted
3 published
Novitium Pharma LLC a subsidiary
US, as the owner printed on each patent
4 granted
6 published
Alimera Sciences, Inc. a subsidiary
US, as the owner printed on each patent
4 granted
2 published
ANI Pharmaceuticals, Inc. its own name
named as the applicant on its applications, in US
0 granted
2 published
Alimera Sciences, Inc. a subsidiary
named as the applicant on its applications, in US
0 granted
1 published
Newest grantseach row opens the USPTO’s own copy
GrantedPatentTitleFieldOwner as printed
Oct 14, 202512,440,542Kits for preparing and delivering purified corticotropinMedical technologyANI Pharmaceuticals, Inc.
Sep 30, 202512,427,108Stable oral liquid composition of terazosinPharmaceuticalsNovitium Pharma LLC
Jul 8, 202512,350,245Stable oral suspensions of baclofenPharmaceuticalsANI Pharmaceuticals, Inc.
Jun 10, 202512,324,787Kits for preparing and delivering purified corticotropinMedical technologyANI Pharmaceuticals, Inc.
Feb 25, 202512,233,105Methods for storing and warming purified corticotropin compositionsMedical technologyANI Pharmaceuticals, Inc.
Nov 5, 202412,133,831Kits for preparing and delivering purified corticotropinMedical technologyANI Pharmaceuticals, Inc.
Oct 1, 202412,102,662Methods for storing and warming purified corticotropin compositionsMedical technologyANI Pharmaceuticals, Inc.
May 7, 202411,975,047Methods for storing and warming purified corticotropin compositionsMedical technologyANI Pharmaceuticals, Inc.
Jan 23, 202411,878,022Hydrochlorothiazide compositionsPharmaceuticalsNovitium Pharma LLC
Jan 2, 202411,857,524Stable oral suspensions of baclofenPharmaceuticalsANI Pharmaceuticals, Inc.
Newest applications publishedan application is a clue, never a plan
PublishedApplicationTitleFieldOwner as printed
Dec 11, 20252025/0375376STABLE ORAL LIQUID COMPOSITION OF TERAZOSINPharmaceuticalsNovitium Pharma LLC
Sep 5, 20242024/0293325TABLET FOR ORAL SUSPENSIONPharmaceuticalsNovitium Pharma LLC
Jun 13, 20242024/0189229LIQUID PHARMACEUTICAL COMPOSITIONS OF BACLOFEN FOR ORAL ADMINISTRATIONPharmaceuticalsANI Pharmaceuticals, Inc.
May 30, 20242024/0173282STABLE ORAL BACLOFEN COMPOSITIONSPharmaceuticalsANI Pharmaceuticals, Inc.
Jan 18, 20242024/0016771STABLE ORAL SUSPENSIONS OF BACLOFENPharmaceuticalsANI Pharmaceuticals, Inc. · patent 12,350,245 granted from it
Dec 14, 20232023/0398078TABLET FOR ORAL SUSPENSIONPharmaceuticalsNovitium Pharma LLC
Apr 13, 20232023/0111273HYDROCHLOROTHIAZIDE COMPOSITIONSPharmaceuticalsNovitium Pharma LLC · patent 11,878,022 granted from it
Jun 16, 20222022/0184094HYDROCHLOROTHIAZIDE COMPOSITIONSPharmaceuticalsNovitium Pharma LLC
Feb 17, 20222022/0047508STABLE ORAL LIQUID COMPOSITION OF TERAZOSINPharmaceuticalsNovitium Pharma LLC · patent 12,427,108 granted from it
Nov 7, 20192019/0336466METHODS OF TREATING RETINAL DISEASESPharmaceuticalsAlimera Sciences, Inc. · patent 11,400,070 granted from it
What it applied for, 2024 to 2025: Pharmaceuticals 5.

A patent is counted where the owner printed on it when it was granted carries the company’s own name, a former name, the name of a subsidiary its annual report lists, or its own name with a patent-holding phrase (Technology Licensing, Intellectual Property and the like), once the legal form, case and punctuation are set aside, and prints a country that name counts in. PatentsView’s data are published under the Creative Commons Attribution 4.0 licence. Source: PatentsView's granted patents and pre-grant publications, disambiguated, from the USPTO's Open Data Portal, through Dec 31, 2025, read Oct 27, 2026.

SI Assistanton ANIP · research, not advice